规格:60mg 相互作用:1.以下药品可能会增加低血糖的危险,禁止联合应用:咪康唑(全身途径,口服凝胶):增加降糖作用并可能会出现低血糖症状,甚至昏迷。 2.不推荐联合应用: (1)保泰松(全身途径):增加磺脲素药物的降糖效应[取代它们与血浆蛋白的结合和(或)减少它们的清除]。最好使用一种相互作用少的消炎药剂,否则,...
Diamicron MR 60 mg Servier, Switzerland; Servier, Philippines; Servier Austria, Austria; Servier Laboratories, Oman Diamicron Uno Servier, Germany; Servier, Denmark; Servier, Iceland Diamicron-60 Servier, Luxembourg Diamin Taiwan Biotech, Taiwan ...
Efficacy and tolerability of gliclazide MR 60 mg in the management of type 2 diabetes: Analysis of the EasyDia TrialDiabetic nephropathy (DN)--is a leading cause of terminal renal failure in the developed countries. Kidney pathology development undergoes several stages--from preclinical structural ...
Though gliclazide MR and glimepiride had similar efficacy, risk of hypoglycemia was significantly lower with gliclazide MR than glimepiride (3.7% vs. 8.9 % of patients; p=0·003). Additionally, intensive glycemic control of <6.5% could be achieved without HEs requiring assistance (Schernthaner et...
Pharmacokinetic data Protein binding Approx 95% Excreted unchanged in urine <5% Volume of distribution 0.24(L/kg) Biological half-life 10-12 (MR: 12-20) / Prolonged SAFETY Risk and Safety Statements Symbol(GHS) GHS07 Signal word Warning Hazard statements H302 Precautionary statements P301...
欧盟HMA上市药品数据库提供Gliclazide 60mg Prolonged Release Tablets药品的基本信息,包括通用名gliclazide,中文名格列齐特,ATC代码A10BB09 gliclazide以及上市许可持有人FOCUS PHARMACEUTICALS LIMITED UNIT 5 FARADAY COURT BURTON UPON TRENT STAFFORDSHIRE DE14 2WX UN
(± metformin) in people with T2D, as measured by changes in HbA1c from baseline to the end of the study. The study is collecting data from adults diagnosed with T2D for at least 2 years and treated with gliclazide MR (≥ 60 mg/day) and an SGLT2i for at least 60 days. Other...
Population PKPD modelling of the long-term hypoglycaemic effect of gliclazide given as a once-a-day modified release (MR) formulation. Br. J. Clin. Pharmacol. 55, 147–157 (2003). Article CAS PubMed PubMed Central Google Scholar Zammitt, N. N. & Frier, B. M. Hypoglycemia in type ...
CM Monzón,CM Teglia,MR Delfino,... - 《Microchemical Journal》 被引量: 1发表: 2016年 Determination of Glimepiride in Rat Serum by Rp-Hplc Method A simple and sensitive reverse phase high performance liquid chromatography (RP-HPLC) method was developed for the determination of glimepiride in ra...
1. Prospective investigation on intensive blood-glucose control of Gliclazide MR capsule in type 2 diabetes; 缓释格列奇特强化治疗2型糖尿病前瞻性研究2) Controlled-release-gliclazide 格列奇特控释片 1. Efficacy and Safety in Type 2 Diabetes Treated by Controlled-release-gliclazide in Comparison with ...